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Abstract 33	  
Upon severe or chronic liver injury, adult ductal cells (cholangiocytes) contribute to 34	  
regeneration by restoring both hepatocytes and cholangiocytes. Recently, we showed 35	  
that ductal cells clonally expand as self-renewing liver organoids that retain their 36	  
differentiation capacity into both hepatocytes and ductal cells. However, the 37	  
molecular mechanisms by which adult ductal-committed cells acquire cellular 38	  
plasticity, initiate organoids and regenerate the damaged tissue remain largely 39	  
unknown.  40	  
Here, we describe that, during organoid initiation and in vivo following tissue 41	  
damage, ductal cells undergo a transient, genome-wide, remodelling of their 42	  
transcriptome and epigenome. TET1-mediated hydroxymethylation licences 43	  
differentiated ductal cells to initiate organoids and activate the regenerative 44	  
programme through the transcriptional regulation of stem-cell genes and regenerative 45	  
pathways including the YAP/Hippo. 46	  
Our results argue in favour of the remodelling of genomic 47	  
methylome/hydroxymethylome landscapes as a general mechanism by which 48	  
differentiated cells exit a committed state in response to tissue damage.  49	  
  50	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The adult liver exhibits low physiological turnover, however it has an efficient 51	  
regenerative ability following damage. Upon tissue injury, if hepatocyte proliferation 52	  
is compromised, resident, lineage-restricted ductal cells (cholangiocytes) acquire 53	  
cellular plasticity to regenerate both, cholangiocytes and hepatocytes1-9. Similarly, in 54	  
vitro, ductal cells grown as clonal organoids become bi-potential, express 55	  
stem/progenitor markers, including Lgr54,10,11, Foxl17 and Trop212, and differentiate 56	  
into both ductal and hepatocyte-like cells in vitro and mature hepatocytes in vivo, 57	  
upon transplantation4,13,14. However, the molecular mechanisms by which adult 58	  
committed cells exit their lineage-restricted state, initiate proliferating organoids and 59	  
respond to damage by generating both ductal cells and hepatocytes remain largely 60	  
unknown. 61	  
During development, epigenetic mechanisms are imposed to ensure that differentiated 62	  
cells remain lineage-restricted15. In mammals, 5-methylcytosine (5mC) is the most 63	  
common DNA modification and is associated to gene repression at promoter and 64	  
enhancer level16-20. DNA demethylation might occur passively, due to loss of DNA 65	  
methylation maintenance during replication or via the conversion of 5mC to 5hmC by 66	  
the Ten-eleven translocation (TET) family of methylcytosine dioxygenase 67	  
enzymes21,22, which results in dilution of 5hmC through DNA replication23. 68	  
Moreover, cytosine demethylation can be achieved by a replication-independent 69	  
mechanism mediated by TETs, whereby 5mC is converted to 5hmC, which can be 70	  
further oxidized and replaced with an unmodified cytosine24,25. 71	  
Erasure of 5mC and TET1 activity are essential for resetting the genome for 72	  
pluripotency, germ-cell specification, imprinting and somatic cell reprogramming26-30. 73	  
During development and postnatal life, Tet1 is essential to maintain the intestinal stem 74	  
cell pool31,	  while Tet2 and Tet3 are required to induce postnatal demethylation in 75	  
hepatocytes32. However, whether epigenetic mechanisms and/or DNA-76	  
methylation/hydroxymethylation play a role in the acquisition of cellular plasticity in 77	  
adult differentiated cells during the regenerative response has not been investigated 78	  
yet. 79	  
Here, we report that in the liver, during the response to tissue damage, adult resident 80	  
ductal cells undergo a genome-wide remodelling of their transcriptional and 81	  
methylome/hydroxymethylome landscapes in the absence of ectopic genetic 82	  
manipulation. We identify TET1-mediated hydroxymethylation and its downstream 83	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regulation of ErbB/MAPK and YAP/Hippo signalling pathways as one of the 84	  
epigenetic mechanisms required for lineage-restricted ductal cells to acquire cellular 85	  
plasticity, establish liver organoids and elicit a full regenerative response. 86	  
87	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Results 88	  
 89	  
Adult non-proliferative ductal cells undergo genome-wide changes in their 90	  
transcriptional landscape during organoid initiation and as a response to tissue 91	  
damage 92	  
We recently reported a liver organoid culture system that allows the clonal and long-93	  
term expansion of mouse4	  and human13	   liver ductal cells as self-renewing bi-potent 94	  
organoids capable of differentiating into ductal and hepatocyte-like cells in vitro and 95	  
in vivo4,13,14,33,34. Using the pan-ductal marker EpCAM after excluding hematopoietic 96	  
and endothelial cells (see methods) we isolated pure populations of ductal cells 97	  
capable of generating organoid cultures from undamaged liver with ~15% efficiency 98	  
(Extended Data Figure 1a). To confirm that organoid formation is not due to a 99	  
subpopulation of proliferating ductal cells, we isolated EpCAM+ cells from 100	  
R26Fucci2a mice35 and tracked their cell cycle dynamics. As reported36, we found 101	  
that virtually all EpCAM+ ductal cells are arrested in G1/G0 (mCherry+/mVenus-102	  
/EpCAM+) (Figure 1a-b and Extended Data Figure 1b), indicating that the organoid 103	  
initiating cells are non-proliferative (Figure 1c). To investigate the molecular basis 104	  
that endows adult committed ductal cells to initiate bi-potent organoids, we first 105	  
estimated the time required for the cells to enter the S/G2/M phase. We found that 106	  
first entry into S-phase takes ~40h from isolation, while subsequent G1 phases 107	  
shortened to ~15h (Figure 1d-e, Extended Data Figure 1c and Movie 1). 108	  
Next, we performed genome-wide gene expression analysis (RNA-sequencing) in 109	  
cells isolated directly from the undamaged tissue (0h), cells collected prior to entry in 110	  
S-phase (12h and 24h) and after proliferation initiation (48h and organoid stage, 6 111	  
days). We found that adult differentiated ductal cells undergo profound transcriptional 112	  
changes during the initiation and formation of organoid cultures. We identified 113	  
>3,000 genes differentially expressed (DE) during the first 24h, prior to S-phase, 114	  
while 900 genes changed after proliferation started (48h vs organoids) indicating that 115	  
most of the organoid transcriptional signature is established within 48h in culture 116	  
(Figure 2a-b, Extended Data Figure 2a and Supplementary Dataset 1).  117	  
We classified the differentially expressed genes into 10 clusters. Genes in cluster 3 118	  
and 7 (increased expression from 48h-onwards), were mainly enriched in cell-cycle, 119	  
while genes in cluster 5, whose expression precedes the onset of proliferation (starts 120	  
at 12h and peaks at 24h), were significantly enriched for chromatin regulators (Figure 121	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2b-c). Of note, 55% (383 out of 698) of the genes from an epigenetic modifiers’ list37 122	  
were differentially expressed, including Polycomb, SWI/SNF members and TETs, 123	  
while some ductal markers were transiently down-regulated (Figure 2d-e and 124	  
Extended Data Figure 2b). These results suggested that epigenetic mechanisms might 125	  
be prominently involved in the initiation of liver organoids from non-proliferative, 126	  
lineage-restricted ductal cells.  127	  
Organoids mimic many aspects of the tissue-of-origin in a dish38, however, they have 128	  
not been used to study the molecular mechanisms of tissue regeneration. Therefore, 129	  
we opted to benchmark our organoid cultures to the in vivo response to tissue damage 130	  
by studying the transcriptional changes that occur in vivo after injury and compare 131	  
these to our organoid findings. For that, we induced liver damage to adult mice by 132	  
administering a 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) 133	  
supplemented diet (Figure 2f). Proliferation initiation began at day 3 (d3) and peaked 134	  
at day 5 (d5) of damage (Figure 2g). Interestingly, also in vivo, ductal cells undergo 135	  
significant genome-wide changes of their transcriptional landscape, with >1,500 136	  
genes differentially expressed between the undamaged and any of the two damage 137	  
time points (Supplementary Dataset 1 and Extended Data Figure 2c-e). Notably, most 138	  
of the transcriptional changes occur at d3, before the significant increase of 139	  
proliferation, resembling our in vitro observations. 140	  
Interestingly, 71.4% of the DE genes in vivo were also found as DE genes in vitro 141	  
(1,108 out of 1,552 genes) and presented similar expression patterns. Specifically, 142	  
epigenetic regulators such as Tet1, Hdac7, Uhrf1 or Dnmt1, hepatoblast markers 143	  
(Foxa3, Sox4) or ductal markers presented similar patterns (Figure 2h-i and Extended 144	  
Data Figure 3a).  145	  
Altogether, these results reveal that both, in vivo and in vitro, ductal cells undergo a 146	  
global rewiring of their transcriptional landscape as a response to tissue damage, and 147	  
validate organoids as a model to study some molecular mechanistic aspects of tissue 148	  
regeneration.  149	  
 150	  
TET1 catalytic activity is required for organoid initiation and expansion  151	  
To identify potential epigenetic regulators required for the activation of ductal cells 152	  
during organoid initiation, we selected some of the DE epigenetic modifiers during 153	  
the first 24h and assessed the effect of their loss-of-function (siRNA knock-down) on 154	  
organoid initiation. We found that depletion of Tet1 significantly impaired organoid 155	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formation, while Tet2 knock-down exhibited a reduction, but was not statistically 156	  
significant (Figure 3a and Extended Data Figure 3b).  157	  
Thus, we further investigated the role of TET1 in organoid initiation and expansion. 158	  
For that, we generated 2 independent TET1 mutant alleles: (1) a conditional allele 159	  
(Tet1flx/flx) enabling the spatiotemporal control of TET1 deletion and (2) a 160	  
hypomorphic allele (Tet1hypo) which displays ~35% of Tet1 mRNA and protein levels 161	  
(Tet1hypo/hypo) compared to WT littermates (Extended Data Figure 3c-e and 162	  
Supplementary Table 1). 163	  
We found that ablation of TET1 in FACS-sorted ductal cells derived from 164	  
RosaCreERT2/Tet1flx/flx abrogated organoid formation (Figure 3b), in agreement with the 165	  
siRNA results (see Figure 3a and Extended Data Figure 3b). In addition, TET1 166	  
depletion in established organoids impaired their expansion (Extended Data Figure 167	  
3f). Organoids generated from the Tet1 hypomorphic mutant mice (Tet1hypo/hypo) 168	  
exhibited reduced 5hmC levels and expansion defects, despite that they could be 169	  
established (Figure 3c-e and Extended Data Figure 3g-k). Organoids derived from 170	  
heterozygous or WT littermates displayed no growth defects (Extended Data Figure 171	  
3h-k). Importantly, ectopic expression of full-length TET1 cDNA (hypo-OE 172	  
organoids), but not a catalytically inactive mutant (TET1H1671Y/D1673A)29,39 (hypo-173	  
OEcat.mut. organoids), rescued all these phenotypes (Figure 3c-e and Extended Data 174	  
Figure 3g/k). Altogether, these results demonstrated that the catalytic activity of TET1 175	  
is required to initiate and propagate liver organoids from lineage-restricted, non-176	  
proliferative, ductal cells. 177	  
 178	  
Genome-wide changes in DNA methylation/hydroxymethylation occur during 179	  
the activation of ductal cells following damage  180	  
Given the crucial role of TET1-mediated hydroxymethylation in organoid initiation, 181	  
we speculated that epigenetic regulation of DNA methylation and 182	  
hydroxymethylation levels could be involved in the ductal regenerative response to 183	  
damage in vivo. For that, we quantified the levels of DNA methylation at single base 184	  
resolution by Whole Genome Bisulfite Sequencing (WGBS) in genomic DNA 185	  
extracted from EpCAM+ ductal cells sorted from undamaged and d3 and d5 DDC-186	  
damaged livers (Figure 4a, Extended Data Figure 4a-c, Supplementary Dataset 2). 187	  
WGBS revealed a global increase in cytosine modification (5mC and/or 5hmC) at d3 188	  
after damage, while d5 and undamaged controls showed similar global levels (Figure 189	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4b) although modifications occurred in the same CpG only in ~50% of the cases 190	  
across the time points analysed (Extended Data Figure 4d). Next, we identified the 191	  
differential levels of cytosine modification in defined regions in a CpG context 192	  
(DMRs) (Extended Data Figure 4e-f). At d3, the majority of DMRs represented a gain 193	  
of modified cytosine (mCpG) compared to undamaged (68%) whereas at d5 and 194	  
between both damage time points, these were mainly associated with a loss in mCpG 195	  
(56%, and 75%, respectively) (Figure 4c and Extended Data Figure 4g). We then 196	  
analysed the levels of mCpG at the TSS (+/- 500bp) of genes transcriptionally up-197	  
regulated after damage. From all up-regulated genes, 32.6% (337 out of 1032) showed 198	  
decreased methylation/hydroxymethylation levels at d3 (Figure 4d-e and Extended 199	  
Data Figure 4h), suggestive of a potential role of demethylation in their transcriptional 200	  
activation.  201	  
Of note, we also found that a significant proportion of all up-regulated genes (34%, 202	  
349 genes out of 1032) presented increased levels of mCpG (Figure 4f and Extended 203	  
Data Figure 4h). Since WGBS cannot discriminate between 5mC and 5hmC, we 204	  
hypothesized that this could be explained by an increased 5hmC. Hence, we 205	  
performed Reduced Representation of Hydroxymethylation Profiles (RRHP), to 206	  
identify 5hmC at single base resolution in the same DNA samples used for the WGBS 207	  
(see Figure 4a and Supplementary Dataset 2). Consistent to 5hmC 208	  
immunofluorescence stainings on ductal cells upon in vivo damage in WT mice or 209	  
upon β1 integrin deletion (a damage model of duct-mediated hepatocyte 210	  
regeneration9)	   and during organoid initiation (Extended Data Figure 5a-c), RRHP 211	  
showed increased 5hmC sites upon damage (Figure 4g and Extended Data Figure 5d). 212	  
To identify 5hmC regulated targets, we analysed 3,581 genes showing differential 213	  
hydroxymethylation levels i.e., presenting ≥4 unique 5hmC sites at their TSS, either 214	  
in undamaged or after damage. Of note, >95% of these genes (3,450 genes) had 215	  
acquired de novo 5hmC sites at d3, prior to proliferation, while most of these de novo 216	  
marks were lost at d5, suggestive of a significant transient reshaping of the 217	  
hydroxymethylome as a response to damage and prior to cell proliferation (Figure 4h-218	  
j and Extended Data Figure 5e). Notably, 5hmC levels did not increase in CpG islands 219	  
(CGI) outside TSS (Extended Data Figure 5f).  220	  
The differentially hydroxymethylated genes could be classified in six clusters (1-6), 221	  
with clusters 2-4 presenting increased 5hmC at day 3 and reduced levels at day 5 and 222	  
cluster 6 (140 genes) showing overall increased 5hmC levels at day 5 (Figure 4j and 223	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Extended Data Figure 5g). When overlapping genes with increased 5hmC with genes 224	  
differentially expressed in vivo we found 154 genes transcriptionally up-regulated 225	  
(Figure 4k and Supplementary Dataset 1). Interestingly, some of these also presented 226	  
increased cytosine modifications in the WGBS at d3, prior to proliferation, hence 227	  
explaining, at least in part, the observed dichotomy between the increased levels of 228	  
modified cytosine in the WGBS and the increase in transcription. Among these, we 229	  
found genes involved in liver regeneration signalling pathways (e.g. Erbb2)40 and 230	  
liver development (Foxa3, Sox4)41	   (Figure 4l).	   In addition, 84 genes showing 231	  
differential 5hmC levels were also down-regulated in vivo, including negative 232	  
regulators of the BMP pathway (Bambi) and genes important for hepatocyte 233	  
differentiation (Cebpa and Atf3) (Extended Data Figure 5h and Supplementary 234	  
Dataset 1). 235	  
Altogether, our genome-wide analyses suggest that transient increase in 236	  
hydroxymethylation levels might facilitate the acquisition of cellular plasticity in 237	  
ductal cells and subsequent initiation of the response to damage. 238	  
 239	  
TET1 induces ductal cell plasticity through the regulation of the YAP/Hippo and 240	  
ErbB/MAPK signalling pathways 241	  
Our findings indicate that hydroxymethylation levels rise upon damage in 242	  
genes/pathways relevant for liver regeneration, at the time where Tet1 expression is 243	  
increased, and before the onset of proliferation. Therefore, we next sought to elucidate 244	  
TET1-regulated genes involved in the acquisition of cellular plasticity during liver 245	  
regeneration. Hence, we investigated TET1 genomic occupancy by performing 246	  
Targeted DamID-seq (DNA Adenine Methyltransferase IDentification 247	  
sequencing)42,43	   (Extended Data Figure 6a). We found 5,102 TET1 specific peaks, 248	  
56% of which were in actively transcribed regions (Extended Data Figure 6b-c and 249	  
Supplementary Dataset 3). We next identified TET1 targets by overlapping the peaks 250	  
to a +/-2Kb region around the TSS. We found 2,358 TET1 target genes in liver 251	  
organoids, 88% of which shared an H3K4me3 peak, indicating that TET1 binding at 252	  
TSS occurs mostly in transcriptionally active genes (Figure 5a). These were involved 253	  
in cell-cycle, transcription and chromatin organisation, among others (Extended Data 254	  
Figure 6d).  255	  
Notably, we identified TET1 binding on stem-cell genes such as Lgr510, Axin244,45	  256	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and Lrig146, the known TET1-target Cdk147,	   epigenetic regulators (Cbx3, Ezh2, 257	  
Dnmt1, Hdac1) and liver development transcription factors (Onecut1 and Onecut2) 258	  
(Figure 5b and Supplementary dataset 3).	   TET1 and 5hmC levels were increased 259	  
before transcription of the stem-cell genes Lgr5, Trop2 and Sulf2, while both, Lgr5 260	  
mRNA and 5hmC were reduced in organoids with low levels of TET1 (TET1hypo/hypo) 261	  
and could be rescued by ectopic expression of TET1 (Figure 5c and Extended Data 262	  
Figure 6e-g). TET1-dependent 5hmC might co-operate with the existing 263	  
transcriptional regulatory machinery, as the recruitment of TET1 to Lgr5, a TCF4 264	  
target48, paralleled the binding of TCF4/Tcf7l2 to the locus (Figure 5c). As expected, 265	  
no TET1 binding or changes in 5mC/5hmC were detected in genes not expressed, 266	  
including the hepatoblast marker Afp and hepatocyte marker Alb (Figure 5b and 267	  
Extended Data Figure 6g). Of note, some TET1 targets were also up-regulated in vivo 268	  
(see Figure 4, Extended Data Figure 4h and Supplementary Dataset 4). The overlap 269	  
between TET1 targets and DE genes in vivo and in vitro (see Figure 2h) suggests that 270	  
TET1 mainly functions as a transcriptional activator in liver ductal cells (Figure 5d 271	  
and Supplementary Dataset 1). 272	  
To further elucidate the mechanism by which TET1-mediated hydroxymethylation 273	  
regulate organoid formation and liver regeneration we performed KEGG pathway 274	  
enrichment analysis on TET1 targets that were also differentially hydroxymethylated 275	  
upon damage in vivo. This revealed a significant enrichment on several 276	  
components/targets of signalling pathways including mTOR, ErbB, MAPK and 277	  
YAP/Hippo, among others (Figure 6a, Supplementary Dataset 2).  278	  
Interestingly, mTOR, ErbB, MAPK and YAP/Hippo have been extensively described 279	  
to be essential for liver regeneration in vivo40,49-53. Additionally, YAP/Hippo and 280	  
mTOR have been recently identified as required for intestinal54 and liver50 organoid 281	  
expansion. Therefore, we hypothesized that the direct regulation of these pro-282	  
regenerative pathways could explain the mechanism by which TET1 facilitates the 283	  
acquisition of cellular plasticity in liver ductal cells upon tissue injury or during 284	  
organoid initiation. We first validated TET1 occupancy by ChIP-qPCR on selected 285	  
TET1 targets [ErbB and MAPK (Egfr, Foxo3, Socsc2, Jun) and YAP/Hippo 286	  
(Wwtr1/Taz, Tead1, Gadd45b and Ctgf)] (Figure 6b). Next, we assessed whether their 287	  
expression was TET1 dependent, by evaluating their mRNA levels following TET1 288	  
depletion in RosaCreERT2/Tet1flx/flx organoids. We found a consistent down-regulation 289	  
of YAP/Hippo pathway components such as Wwtr1/Taz and Tead1 and target genes 290	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such as Gadd45b and Ctgf upon TET1 knock-down (Figure 6c). The expression levels 291	  
of these, except for Gadd45b, were rescued in TET1 hypo-OE organoids (Figure 6d). 292	  
For several of the components and targets of the ErbB/MAPK pathways (Egfr, Foxo3, 293	  
Jun) we detected both, up- or down-regulation following TET1 knock-down (Figure 294	  
6c).  295	  
Thus, we evaluated whether TET1-dependent regulation of these pathways is 296	  
involved in the acquisition of cellular plasticity during organoid formation. We 297	  
confirmed TET1 binding to some of these targets at 18hrs after seeding (Figure 6e). 298	  
To elucidate whether ErbB, MAPK and YAP/Hippo signalling act down-stream of 299	  
TET1, we then supplemented the cultures with small molecule inhibitors of the 300	  
aforementioned pathways (Gefitinib (EGFRi), PD032509 (MEKi) and Verteporfin 301	  
(YAPi)) for the first 18h in culture (0-18hrs), i.e., before TET1 binding, and at 18hrs-302	  
48hrs, i.e., after TET1 binding, and evaluated organoid formation efficiency 6 days 303	  
later. Treatment at 18-48hrs, once TET1 is bound to its targets, induced a significant 304	  
decrease of organoid formation, thus suggesting that the regulation of ErbB, MAPK 305	  
and YAP/Hippo signalling could represent one of the mechanisms by which TET1 306	  
positively regulates organoid formation from mature liver ductal cells (Figure 6f). 307	  
Conversely, treatment before TET1 binding (0-18h) or inhibition of FGFR1/3 did not 308	  
cause any significant effect on organoid formation (Figure 6f and Extended Data 309	  
Figure 7a). mTOR inhibition instead, resulted in ablation of organoid formation 310	  
regardless of the time of supplementation, suggesting that either this pathway is 311	  
essential during the first 18h for ductal cell survival in vitro or is not regulated by 312	  
TET1 (Extended Data Figure 7a). Thus, our results suggest that TET1 promotes the 313	  
acquisition of cellular plasticity in ductal cells, at least in part, via the regulation of 314	  
YAP/Hippo and ErbB, MAPK signalling pathways. 315	  
 316	  
TET1 is required for ductal-mediated hepatocyte and cholangiocyte 317	  
regeneration  318	  
To elucidate whether TET1 is relevant for liver regeneration, we induced liver 319	  
damage to the Tet1 hypomorphic and ductal specific Tet1 mutant mice. As damage 320	  
paradigms, we opted for three different models: (1) acute damage with 5 days DDC 321	  
treatment; (2) chronic damage caused by repetitive doses of DDC and (3) a damage 322	  
model where hepatocyte proliferation is impaired by over-expression of p21 and 323	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ductal cells have been demonstrated to regenerate both themselves and hepatocytes 324	  
2,8,9 (Supplementary Table 1).  325	  
To address the role of TET1 during acute liver damage we used the TET1 326	  
hypomorphic allele (Tet1hypo/hypo), since the conditional RosaCreERT2 /Tet1flx/flx exhibited 327	  
partial lethality upon Cre induction, in agreement with the published TET1 full KO31 328	  
(Supplementary Table 1). Tet1hypo/hypo mice presented no obvious phenotype under 329	  
homeostasis (Extended Data Figure 8a-d). However, upon damage, it exhibited 330	  
significantly lower number of proliferating liver ductal cells (Ki67+/OPN+ cells) and 331	  
absolute number of liver ductal cells when compared to WT control littermates 332	  
(Figures 7a-b and Extended Data Figure 8e-h). Notably, this reduced proliferation of 333	  
the ductal compartment was not explained by differences in the extent of liver damage 334	  
between genotypes (Extended Data Figure 8b and d).  335	  
Interestingly, upon chronic liver damage, Tet1hypo/hypo mice presented extended 336	  
fibrosis (Figure 7c-d). Since Lgr5 depletion in vivo results in tissue fibrosis55	   we 337	  
evaluated the levels of Lgr5 in our mutant mice and found reduced expression and 338	  
less hydroxymethylation of Lgr5 loci in Tet1hypo/hypo mice (Extended Data Figure 8i).  339	  
To discriminate whether the defects on liver regeneration observed were caused by 340	  
the lack of TET1 expression in the adult ductal compartment, we generated a ductal-341	  
specific TET1 mutant mouse by crossing the Tet1flx/flx allele with the ductal specific 342	  
driver Prom1CreERT2 (Extended Data Figure 9a and56,57).	   To visualise and trace 343	  
recombination events, we further combined this mouse with the RosalslZsGreen reporter 344	  
to generate the Prom1CreERT2/RosalslZsGreen/Tet1flx/flx, referred here as Prom1∆Tet1/ZsGreen 345	  
in contrast to the TET1 WT, named here as Prom1Tet1WT/ZsGreen mice. We confirmed 346	  
the reliability of the ZsGreen to reflect TET1 levels after recombination. No ZsGreen 347	  
induction was found without tamoxifen treatment (Extended Data Figure 9b-d).  348	  
To assess the role of TET1 in ductal-mediated liver regeneration, we used a recently 349	  
established liver damage model where hepatocyte proliferation is inhibited by p21-350	  
over-expression9	  and fed the mice DDC for 3 weeks	   (Figure 8a and Extended Data 351	  
Figure 9e-f). We observed	  a massive expansion of ductal cells (OPN+/ZsGreen+) in 352	  
Prom1Tet1WT/ZsGreen mice while Prom1∆Tet1/ZsGreen mice exhibited a significant reduction 353	  
(Figure 8b-c), in agreement with our Tet1 hypomorphic model (see Figure 7a-b). 354	  
Notably, when we examined the contribution of TET1 depleted ductal cells to 355	  
hepatocyte regeneration, we observed a dramatic reduction in the size of hepatocyte 356	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clusters in the Prom1∆Tet1/ZsGreen mice, with most clusters formed by 1-2 cells only, 357	  
while Prom1Tet1WT/ZsGreen mice readily generated hepatocyte clusters from 1 to 156 358	  
cells (Figure 8d-e).  359	  
Molecular analysis of TET1-null ductal cells upon damage indicated that also in vivo 360	  
TET1 binds to the TSS and regulates the expression of some genes from the pro-361	  
regenerative YAP/Hippo and ErbB/MAPK signalling pathways (namely Egfr, 362	  
Gadd45b, Wwtr1/Taz and Tead1) (Extended Data Figure 9g-h), in line with our 363	  
organoid data (see Figure 6).  364	  
Altogether, our studies demonstrate that TET1 plays a crucial role in ductal-driven 365	  
liver regeneration, at least in part, through the direct activation of the YAP/Hippo and 366	  
ErbB/MAPK signalling pathways.   367	  
  368	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Discussion  369	  
Many adult epithelial tissues exhibit cellular plasticity not associated with unrelated 370	  
fates, but with contribution to tissue repair (see58 for extended details). Under 371	  
homeostasis a unipotent population of hepatocytes maintain the tissue45,59,60.	  372	  
Following hepatocyte injury, the lost tissue is repaired by remaining hepatocytes61. 373	  
However, upon severe or chronic liver damage, mature cholangiocytes activate a 374	  
regenerative response to restore both themselves and hepatocytes5,9,62,63. Yet, the 375	  
molecular mechanisms behind the activation of this cellular plasticity on liver resident 376	  
ductal cells remain largely unknown. This knowledge is critical to understand human 377	  
liver diseases characterized by prominent ductal proliferation and hepatic fibrosis64,65.  378	  
Here we demonstrate that upon damage and during organoid formation resident ductal 379	  
cells undergo genome-wide changes in their transcriptional landscape and a 380	  
significant remodelling of their DNA methylome and hydroxymethylome. We 381	  
identify demethylation and TET1-mediated hydroxymethylation as an epigenetic 382	  
mechanism required for ductal cell activation in vitro and in vivo, after damage 383	  
(Figure 8f). The acquisition of the cellular plasticity that endows differentiated ductal 384	  
cells with regenerative capacity in vivo, might occur through a progenitor state, as our 385	  
organoid data imply. However, whether in vivo, new cells are provided through a 386	  
direct division of differentiated cells, via de-differentiation to a progenitor state, by 387	  
direct trans-differentiation or a combination of all these66, remains unknown and will 388	  
require further and more extensive investigations.  389	  
Cancer cell lines and liver cancer, exhibit relatively low levels of 5hmC67,68. In 390	  
contrast, our results, indicate that transient high levels of 5hmC are required to induce 391	  
ductal cells to activate the regenerative program, similar to what has been reported in 392	  
pluripotent cells39. TET enzymes have been shown to promote genome integrity in 393	  
mouse ES cells69. Hence, it is tempting to speculate that transient Tet1 induction 394	  
during liver damage might be a mechanism for activating the regenerative program in 395	  
ductal cells while preserving genome integrity in the regenerating cell.  396	  
Interestingly, our analyses indicate that the mechanism by which TET1 facilitates the 397	  
acquisition of cellular plasticity and subsequent pro-regenerative effect is, at least in 398	  
part, through the direct regulation of ErbB, MAPK and YAP/Hippo regenerative 399	  
pathways40,50-53. Whether other genes transcriptionally activated/repressed by TET1 400	  
are involved in the process requires further investigations.  401	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Notably, the rewiring of the transcriptome and DNA methylome and 402	  
hydroxymethylome occurs prior to proliferation, as a response to tissue damage and in 403	  
the absence of any ectopic genetic manipulation. This mechanism resembles 404	  
embryonic reprogramming, where genome-wide methylation erasure is essential to 405	  
reset the epigenome for pluripotency28. Our observations might represent a more 406	  
general mechanism by which adult committed cells initiate the regenerative response 407	  
to damage.  408	  
  409	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 462	  
Figure Legends: 463	  
 464	  
Fig. 1: G1/G0 arrested liver ductal cells require ~48h to start cell proliferation 465	  
and initiate liver organoids cultures 466	  
R26Fucci2a mice constitutively express a bi-cistronic cell-cycle reporter that allows 467	  
discriminating between G1/G0 [Cherry-hCdt1+ (30/120), red] and S/G2/M [Venus-468	  
hGem+, (1/110) green] phases of the cell cycle. a, Experimental approach b, EpCAM+ 469	  
liver ductal cells from R26Fucci2a mice were FACS-sorted according to the 470	  
expression of mCherry-hCdt1 (C) and/or mVenus-hGem (V). The graph represents 471	  
percentage of EpCAM+ cells positive for mCherry and/or mVenus. Each dot 472	  
represents an independent experiment from an independent mouse (n=3). Graph is 473	  
presented as mean±SD of 3 independent experiments. c, Representative bright field 474	  
images of 500 C+/V- EpCAM+ and C-/V- EpCAM+ cells cultured for 6 days as liver 475	  
organoids. The graph represents mean±SD of organoid formation efficiency (n=3 476	  
experiments). p-value was calculated using Student's two tailed t-test. **, 477	  
p=0.001413095. d, Still images from a representative movie of C+/V- EpCAM+ ductal 478	  
cells monitored for 72h using a spinning-disk confocal microscope. Scale bars, 10µm. 479	  
e, Graph represents G0/G1 length for the first (I) and second (II) cell cycles since 480	  
t=0h (isolation) of n=34 cells, pooled from 3 independent experiments). Global mean 481	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of G0/G1 length	  is shown (G0/G1 I = 37.97 h, hours; G0/G1 II = 10.20 h, hours). h, 482	  
hours. 	  483	  
 484	  
Fig. 2: Liver ductal cells undergo genome-wide changes in their transcriptional 485	  
landscape during organoid initiation and in vivo upon damage  486	  
a-e, Expression analysis of ductal cells during organoid initiation. a, Experimental 487	  
Scheme. Graph represents DE genes (pairwise approach with Wald test performed 488	  
using Sleuth. Threshold FDR <0.1) b, Hierarchical clustering of all 7580 DE genes. 489	  
Heatmap represents averaged TPM values of biological replicates scaled per gene (Z-490	  
score). Number in bold, cluster. n, number of genes/cluster. c, GO and statistical 491	  
analyses were performed using DAVID 6.8. Red, cluster containing DE genes at 12h 492	  
and 24h. d, Heatmaps representing averaged Z-score of indicated genes. e, Graphs 493	  
represent mean±SD of n=6 independent RT-qPCR experiments. Independent 494	  
experimental data are listed in Source Data. Data are presented as fold-change 495	  
compared to t=0h. p-value is calculated using two-way ANOVA combined with 496	  
Tukey HSD test. p-value of comparisons vs t=0 are shown. **, p<0.01; ***, p<0.001. 497	  
Exact p-values are provided in Source Data. f-i, Expression analysis of ductal cells 498	  
following liver damage by supplementing the diet with 0.1% DDC (see methods). f, 499	  
Experimental scheme. g, Immunofluorescence analysis of ductal cell proliferation 500	  
upon damage. Representative images are shown (3 experiments). Scale bar, 50µm. 501	  
Graph represents mean±SD of proliferating ductal cells (undamaged n=3 mice, DDC 502	  
d2 n=3 mice, d3 n=4 mice, d5 n=4 mice). p-values were calculated vs undamaged 503	  
using pairwise comparisons with Wilcoxon rank sum test (DDC d3 p= 0.01201; DDC 504	  
d5 p= 7.6E-05). *, p<0.05; ***, p<0.001. h, RNA sequencing analysis of sorted 505	  
EpCAM+ ductal cells isolated from undamaged or DDC-treated livers (2 livers have 506	  
been assessed per time point). Venn diagram, overlap between DE genes in vitro and 507	  
in vivo. p-value is calculated using normal approximation of the hypergeometric 508	  
probability. Table indicates the GO analysis (top 3 significant categories) of the 7 509	  
clusters identified in i (Cluster 1 n=183; Cluster 2 n=276; Cluster 3 n=260; Cluster 4 510	  
n=69; Cluster 5 n= 76; Cluster 6 n= 154; Cluster 7 n=90) and their p-values obtained 511	  
with DAVID 6.8. i, Heatmap (averaged Z score) of the hierarchical clustering of the 512	  
1108 DE genes based on the in vitro expression profile. Number in bold, cluster. n, 513	  
number of genes/cluster.  514	  
 515	  
Fig. 3: TET1 catalytic activity is required for liver organoid initiation and 516	  
maintenance 517	  
a, FACS-sorted EpCAM+ ductal cells freshly isolated from WT undamaged livers 518	  
were transfected with a pool of siRNAs, each of them targeting specifically a selected 519	  
epigenetic modifier, and organoid formation efficiency was evaluated 10 days later. 520	  
Results are shown as percentage of organoid formation efficiency compared to mock 521	  
transfected cells. The graph represents mean±SD of n=3 independent experiments 522	  
(dots). p-values were calculated using  one-way ANOVA in conjunction with Tukey’s 523	  
HSD test by comparison to siCtrl. *, p= 0.01031057 siTet1 vs siCtrl,.	  b, FACS-sorted 524	  
EpCAM+ ductal cells derived from RosaCreERT2 x Tet1flx/flx mouse livers were plated 525	  
in organoid isolation medium supplemented with 5µM hydroxytamoxifen or vehicle 526	  
and organoid formation efficiency was evaluated 6 days later. Representative bright 527	  
field images are shown. Data are reported as percentage of organoid formation 528	  
compared to Cre-Tam- cells. Graphs represent mean±SD of n=3 independent 529	  
experiments. p-value was calculated using Student's two-tailed t-test vs Cre-Tam-  (*, 530	  
Cre-Tam+ p=0.03781815; ***, Cre+Tam+ p=4.812E-05).	   c-e, EpCAM+ ductal cells 531	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isolated from Tet1 hypomorphic mice were used to generate liver organoids 532	  
(Tet1hypo/hypo, blue) or were transfected with a hTET1 full length cDNA (hypo-OE 533	  
organoids, red) or catalytically inactive hTET1 H1671Y/D1673A (hypo-OEcat.mut. 534	  
organoids, turquoise). Organoids derived from WT littermates were used as controls 535	  
(black). c, Scheme indicates the lines generated. d, Western blot analysis of TET1 536	  
protein levels. The graph represents TET1 levels. Complete blot is shown in data 537	  
source. Results are presented as mean±SD of n=3 independent experiments (dot). **, 538	  
p-value calculated using Student's two-tailed t-test vs WT (Tet1hypo/hypo 539	  
p=0.006779543). e, Representative bright field images of WT (2 line), Tet1hypo/hypo(4 540	  
line) hypo-OE (1 line) and hypo-OEcat.mut. (1 line) organoid lines at passage 3. 541	  
Graph indicates passage number.	  542	  
 543	  
Fig. 4: Liver ductal cells undergo global remodelling of DNA methylation and 544	  
hydroxymethylation landscapes in vivo upon damage 545	  
a-l, gDNA from undamaged or DDC-damaged livers was split in two fractions and 546	  
prepared for WGBS (a-f) or RRHP (g-l) (2 mice per time point). a, Experimental 547	  
design. b, Graph shows the percentage of modified CpG (mCpG) sites according to 548	  
different level categories (average of replicates). c, Number of differentially 549	  
methylated/hydroxymethylated regions (DMRs) present in the n=2 biological 550	  
replicates. DMR were called based on a modification difference ≥25%, p<0.05 (see 551	  
methods). d-e, Graphs (mean±95%CI) represent percentage of modified cytosines at 552	  
TSS for all n=337 up-regulated genes (d) or selected ones (e) showing decreased 553	  
mCpG levels at d3 (average of replicates). p-value was obtained by Kruskal Wallis 554	  
test with Dunns multiple comparison. ****, undamaged vs d3 p<0.0001, ***, 555	  
undamaged vs d5 p=0.0003, d3 vs d5 p=0.0004. TET1 targets (see Figure 5) are 556	  
represented in bold red. f, Graph represents all n=349 up-regulated genes after 557	  
damage presenting increased mCpG level at TSS (mean ±95% CI). p-value was 558	  
obtained by Kruskal Wallis test with Dunns multiple comparison. ****, undamaged 559	  
vs d3 p<0.0001, undamaged vs d5 p=0.3773, d3 vs d5 p<0.0001. g, Distribution of 560	  
total 5hmC sites identified. h, Number of genes showing ≥4 5hmC sites around their 561	  
TSS. i, Graph represents median±IQR of 5hmC counts from the n=3581 genes 562	  
differentially hydroxymethylated. p-value was obtained using Kruskal Wallis test 563	  
coupled with Dunn’s multiple comparison. All p-values are <0.0001. ****, p<0.0001 564	  
j, The heatmap represents the z-score values of 5hmC absolute count. 5hmC levels 565	  
were classified into 6 clusters. n, number of genes/cluster. Graphs (median±IQR) 566	  
represent the number of 5hmC counts of differentially hydroxymethylated genes. p-567	  
value was obtained by Kruskal Wallis test with Dunns multiple comparison. All p-568	  
values correspond to p<0.0001 (****), except for ***, p=0.0009. k, Heatmap 569	  
represents Z-score of the 154 overlapping genes. l, Graph represents the levels of 570	  
mCpG from the 154 genes identified in k averaged for the 2 biological replicates. In 571	  
k-l, TET1 targets (see Figure 5) are represented in bold red.  572	  
 573	  
Fig. 5: TET1 regulates the activation of genes involved in organoid formation 574	  
and liver regeneration  575	  
a-b, TET1-DamID analyses were performed in 3 independent experiments. a, 576	  
Heatmaps of TET1-DamID (left) and H3K4me3 (right) binding at the TSS  Venn 577	  
diagram indicates the overlap between the DamID-seq TET1 and H3K4me3 target 578	  
genes identified by ChIP-seq. b, Genome tracks of TET1 (Dam-ID) and H3K4me3 579	  
(ChIP) peaks on selected genes. Graphs show TET1-Dam/Dam only ratio (blue) and 580	  
H3K4me3 number of reads (green). c, Sorted EpCAM+ cells from WT undamaged 581	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livers were cultured as organoids and analysed at the indicated time points (n3 582	  
experiments). Upper panels: hMeDIP (dots, green) and MeDIP (squares, red) levels in 583	  
the indicated genomic region upstream and downstream of the Lgr5 TSS. Lower 584	  
panels: TET1 (blue), TCF4 (brown) and H3K4me3 (purple) ChIP-qPCR at the TSS. 585	  
mRNA expression is shown in black. p-value was obtained using Student's two-tailed 586	  
t-test. Statistical analyses were performed vs t=0h. (Upstream 5hmC 12h 587	  
p=0.004305136, 18h, p=3.26345E-05, 48h p=8.36527E-06; 5mC 12h p=0.009532377, 588	  
18h, p=0.001130234, 48h p=0.001564496; TSS 5hmC 12h p=0.011044339, 18h, 589	  
p=0.005230947, 48h p=0.000485153; Downstream 5hmC 18h, p=0.004305136, 48h 590	  
p=3.26345E-05; 5mC 48h p=8.36527E-06; Lgr5 mRNA 48h p=0.001991489; TET1 591	  
ChIP 12h p=0.005403182, 18h, p=0.003789515, 48h p=0.000119801; H3K4me3 592	  
ChIP 48h p= 0.000774002). *, p<0.05; **, p <0.01***; p <0.001. d, Overlap between 593	  
the n=1108 DE genes identified in Fig. 2h-i and TET1 targets identified by DamID-594	  
seq. p-value of the overlap is calculated using normal approximation of the 595	  
hypergeometric probability. The heatmap (TPM, z-scored) presents the expression 596	  
profile of the 216 TET1 targets DE in vivo and in vitro. Graphs show the gene 597	  
expression levels of n=216 genes (median±95% CI) as ln(TPM +1). p-values are 598	  
obtained with one-way ANOVA followed by Tukey’s multiple comparisons test. 0h 599	  
vs 48h p=0.0379, 0h vs Org p=0.0039; Und vs d3 p=0.0013, Und vs d5 p<0.0001.*, 600	  
p< 0.05; **, p <0.01; ***, p <0.001.  601	  
 602	  
Fig. 6: Tet1 regulates YAP/Hippo and ErbB, MAPK signalling pathways 603	  
a, KEGG pathway enrichment and statistical analyses on the genes identified as 604	  
TET1-DamID targets in liver organoids (n=3) and showing differential levels of 605	  
5hmC in vivo from RRHP using DAVID 6.8. b, TET1 ChIP-qPCRs in liver 606	  
organoids. Data are reported as percentage of input. Graph represents mean ±SD of 607	  
n=3 independent experiments. c, mRNA expression levels of selected TET1 targets in 608	  
WT or RosaCreERT2 x Tet1flx/flx organoids both treated with 5µM tamoxifen for 609	  
24hrs. Cells were harvested 24hrs after tamoxifen treatment. Data are reported as fold 610	  
change compared to Ctrl. Graph represents mean±SD of n=3 independent 611	  
experiments. p-value obtained using Student's two tailed t-test upon comparison to 612	  
Ctrl. Egfr, p= 0.000479886; Foxo3, p= 0.031392276; Jun, p= 0.004319905; Gadd45b, 613	  
p= 0.023554286; Ctgf, p= 0.005333732; Wwtr1, p= 0.000230442; Tead1, p= 614	  
0.002322422. *, p<0.05; **, p<0.01; ***, p<0.001. d, mRNA expression levels of 615	  
YAP/Hippo TET1 targets in Tet1hypo/hypo organoids and TET1hypo-OE organoids. Graph 616	  
represents mean±SD of n=3 independent experiments. p-value obtained using 617	  
Student's two tailed t-test upon comparison to WT. Gadd45b, Tet1hypo/hypo p= 618	  
6.00424E-05; TET1hypo-OE p= 6.24089E-05. Ctgf, Tet1hypo/hypo p= 0.000677729; 619	  
TET1hypo-OE p= 0.001247481. Wwtr1, Tet1hypo/hypo p= 0.002222631; TET1hypo-OE p= 620	  
0.010861863. Tead1, Tet1hypo/hypo p= 0.009343297; TET1hypo-OE p= 0.013645094. *, 621	  
p<0.05; **, p<0.01; ***, p<0.001 e, TET1 ChIP-qPCRs in EpCAM+ FACS-sorted 622	  
cells grown in organoid conditions for 18hrs. Data are reported as percentage of input. 623	  
Graph represents mean ±SD of n=3 independent experiments. f, EpCAM+ ductal cells 624	  
freshly isolated from undamaged livers were treated at 0-18hrs or 18-48hrs with the 625	  
small molecule inhibitors as indicated. Organoid formation was quantified at day 6. 626	  
Graph represents organoid formation efficiency and indicates mean ±SD of n=6 627	  
independent experiments. Statistical analyses were performed with two-ways 628	  
ANOVA with Bonferroni’s multiple compared test vs DMSO control group. 18-48hrs 629	  
Gefitinib, p<0.0001; PD0325901 p<0.0001; Verteporfin, p=0.0039. **, p<0.01; ***, 630	  
p<0.001. Representative pictures of organoids are shown.  631	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Fig. 7: Tet1 hypomorphic mice exhibit reduced ductal regeneration and 632	  
extensive fibrosis upon damage 633	  
a-b, WT (grey) and Tet1hypo/hypo mice (blue) were fed normal chow or a chow 634	  
supplemented with 0.1% DDC for 5 days. a, Representative images of 635	  
immunofluorescence staining for the ductal marker OPN (red) and the proliferation 636	  
marker Ki67 (white). Scale bar, 25µm. PV, portal vein. Graphs represent the 637	  
percentage of proliferating (Ki67+) ductal cells (OPN+) (median±IQR) obtained from 638	  
55 FOV for WT (n=3) and 56 FOV for Tet1hypo/hypo mice (n=3) at day 0 (undamaged), 639	  
and 253 FOV for WT (n=7) and 169 FOV for Tet1hypo/hypo (n=6) at day5 of DDC 640	  
damage. Data are represented a boxplots showing the median, IQR and overall range. 641	  
Grey dots, outliers from a single counted FOV defined as >1.5 IQR above or below 642	  
the median. Red squares, median level corresponding to each independent mouse. p-643	  
values were obtained using two-sided Kolmogorov-Smirnov test. ***, p< 2.2x10-16. 644	  
b, Histogram showing the population distribution of proliferating ductal cells (OPN+, 645	  
Ki67+) by plotting frequency density of counts across the sample range (bar) and the 646	  
kernel density estimate line. Dashed lines show median values. c-d, WT (grey) and 647	  
Tet1hypo/hypo (blue) mice were fed normal chow or a chow supplemented with 0.1% 648	  
DDC for 5 days for 8 consecutive cycles as described in the scheme and methods. 649	  
Liver tissues were collected 3 months after the last cycle and PicroSirius red staining 650	  
was performed to analyse the levels of fibrosis (collagen deposition). c, 651	  
Representative images of PicroSirius red staining (red) (3 mice per time point). Scale 652	  
bar, 200µm. d, Graph represents mean±95% CI of the area of collagen deposition per 653	  
FOV (n=3 mice per time point per genotype). Statistical analysis was performed on 654	  
the 3 mean values per genotype compared to undamaged using Student's two-tailed t-655	  
test. *, p<0.05. 656	  
 657	  
Fig. 8: Ductal specific TET1 depletion results in impaired hepatocyte 658	  
regeneration 659	  
a, Experimental Scheme. b, Representative images of 10µm liver sections showing 660	  
ZsGreen+ ductal cells (OPN+) (n=9 per genotype). Scale bar, 50µm c, Graph showing 661	  
median±IQR of average OPN+ cells per FOV for each individual mouse (n=9 per 662	  
genotype). Global median level is highlighted in red. p-value was calculated using 663	  
Wilcoxon rank sum test. *, p= 0.03768. d, Representative images of 50µm frozen 664	  
liver sections showing regenerative clusters of ZsGreen+ hepatocytes (HNF4a+) and 665	  
ductal cells (OPN+). Scale bar, 50µm. e, Cumulative relative frequency plots (top 666	  
graph) and corresponding box plots (bottom graph) showing median (red), upper and 667	  
lower quartiles and the range (dots represent outliers) of ZsGreen+  hepatocyte cluster 668	  
size of Prom1TET1WT/ZsGreen (n=3) and Prom1∆Tet1/ZsGreen (n=6) mice. p-value was 669	  
determined by two sided Kolomogorov-Smirnov test. ***, p< 2.2x10-16. f, 670	  
Experimental model. 671	  
  672	  
Extended Data Figure 1: Non-proliferative EpCAM+ ductal cells initiate 673	  
organoid cultures 674	  
a, EpCAM+ ductal cells were isolated from WT livers by FACS using a sequential 675	  
gating strategy as follows: cells were gated for FSC and SSC and subsequently 676	  
singlets were gated using  FSC/Pulse width. Then, cells were negatively selected for 677	  
PE/Cy7 (to exclude CD11b+, CD31+ and CD45+ cells) and positively selected for 678	  
APC (EpCAM+) to obtain CD11b-/CD31-/CD45-/EpCAM+ ductal cells (EpCAM+ 679	  
cells). These cells give rise to proliferative organoids with ~15% efficiency. 680	  
Representative bright field pictures of 500 EpCAM+ and EpCAM- cells 6 days after 681	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seeding. Graph represents mean ±SD of n=3 independent experiments. b, RT-qPCR 682	  
analysis of gene expression of the proliferation marker mKi67 (left) and stem-cell 683	  
(Lgr5) and ductal (Epcam and Sox9) markers (right) at the indicated time points after 684	  
seeding. Graphs represent the mean of n=3 independent experiments. p-value 685	  
obtained using Student's two tailed t-test upon comparison to t= 0h. *, p<0.05; ***, 686	  
p<0.001. c, Proliferation analysis. EdU (10µM) was incorporated to sorted EpCAM+ 687	  
ductal cells at different intervals after seeding (0h, 24h and 48h, arrows) and 688	  
evaluated by immunofluorescence analysis 24h after each incorporation. 689	  
Representative images are shown. Scale bar, 10µm. Graph represents the percentage 690	  
of EdU+ cells. Results are expressed as mean±SD cells from n=3 independent 691	  
experiments. Student's two tailed t-test statistical analyses were performed vs t=24h. 692	  
*, p<0.05; **, p<0.01; ***, p<0.001 693	  
 694	  
Extended Data Figure 2: Transcriptional changes in ductal cells in vitro during 695	  
liver organoid formation and in vivo upon damage 696	  
a-e, RNA-seq analysis of ductal cells isolated from adult livers (0h) and at different 697	  
time points after culture.  For DE genes, a pairwise approach with Wald test was 698	  
performed on each gene using Sleuth. FDR <0.1 was selected as threshold. a, Graphs 699	  
represent the number of significantly DE genes for each comparison. b, Hierarchical 700	  
clustering analysis of epigenetic regulators found DE (383 out of 698 published in ref 701	  
49), in at least one comparison. Heatmap represents averaged TPM values scaled per 702	  
gene. Results are presented as the averaged gene expression of the biological 703	  
replicates. n, number of replicates. c-e, RNA-seq analysis of ductal cells isolated from 704	  
adult livers (0h) and at day 3 and day 5 after liver damage (2  mice were assessed per 705	  
time point). The heatmap shows the 1552 DE genes at least in one comparison 706	  
(TPM>5, FDR<0.1, |b|>0.58). Clustering analysis identified 5 different clusters 707	  
(Clusters 1-5) according to the expression profile (Cluster 1 n=835; Cluster 2 n=185; 708	  
Cluster 3 n=503; Cluster 4 n=20; Cluster 5 n=9). Number of genes in each cluster is 709	  
indicated in brackets. Results are presented as average of the at least 3 biological 710	  
replicates. d, Graph represents the number of significant DE genes in the different 711	  
comparisons. e, GO and statistical analyses of the 3 main clusters identified in c were 712	  
performed using DAVID 6.8. 713	  
 714	  
Extended Data Figure 3: TET1 catalytic activity is required for liver organoid 715	  
formation and maintenance 716	  
a, Tet1 and Lgr5 mRNA levels (n=3 mice). Student's two-tailed t-test statistical 717	  
analyses were performed vs undamaged. b, Tet1 mRNA levels (24h after transfection) 718	  
and organoid formation efficiency 10 days after Tet1 siRNA knock-down using 4 719	  
independent Tet1 siRNAs. Data is presented as percentage relative to siCtrl. Graph 720	  
indicates mean±SD of n=3 independent experiments. Student's two-tailed t-test 721	  
statistical analyses were performed vs siCtrl. c, Scheme of the two different Tet1 722	  
alleles used. d, Tet1 mRNA levels in WT, Tet1hypo/+ and Tet1hypo/hypo and Tet1 723	  
conditional knock-out (cKO) organoids presented as mean±SD of n=3 experiments. e, 724	  
Representative Western blot image showing TET1 protein levels in WT, Tet1hypo/+ and 725	  
Tet1hypo/hypo organoids (3 independent experiments). f, Organoid formation efficiency 726	  
from FACS-sorted EpCAM+ cells derived from RosaCreERT2 x Tet1 flx/flx livers treated 727	  
with 5µM hydroxytamoxifen (mean±SD of n=3 independent experiments). Student's 728	  
two-tailed t-test statistical analyses were performed vs non-induced control. g, Whole 729	  
mount immunofluorescence staining of 5hmC (green) on WT, Tet1hypo/hypo, hypo-OE 730	  
and hypo-OEcat.mut. organoids. Representative images are shown (2 experiments). 731	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Scale bar, 50 µm. h, Graph represents organoid size at the indicated passages 732	  
(mean±SD of n=3 independent experiments). Student's two tailed t-test statistical 733	  
analyses were performed vs WT. i, Growth curves. j, Organoid formation efficiency 734	  
at the indicated passage expressed as a percentage of organoids. Graphs represent 735	  
mean±SD of n=3 independent experiments. Student's two tailed t-test statistical 736	  
analyses were performed vs WT. k, Representative confocal images of Cleaved 737	  
Caspase 3 whole mount immunostaining on WT, Tet1hypo/hypo, hypo-OE and hypo-738	  
OEcat.mut. organoids (2 independent experiments). Scale bar, 25µm.  739	  
 740	  
Extended Data Figure 4: WGBS of ductal cells upon damage uncovers a global 741	  
epigenetic remodelling of the DNA methylome  742	  
a, Number of WGBS unique mapped reads in the different biological replicates. b, 743	  
Bisulfite conversion rate. c-h, WGBS analyses were performed in merged biological 744	  
replicates per time point (n=2). Only CpG sites with ≥3 reads were further analysed. 745	  
c, CpG counts in merged biological replicates per time point. d, Genome-wide 746	  
Spearman’s correlation score at the time points analysed shows dynamic CpG 747	  
modifications. e, Functional localisation of DMRs. DMRs were called if the 748	  
difference in cytosine modification between samples was ≥25% with a p-value of 749	  
<0.05, using DSS software. f, Violin plot of the DMR length distribution (in base 750	  
pairs) identified in the n=2 biological replicates. Lines and numbers, median. g, 751	  
Density plot indicating the difference in mCpG levels for loss/gain DMRs for each 752	  
comparison. h, Venn diagram showing the overlap between TET1 targets (see Figure 753	  
5) that are transcriptionally up-regulated and genes showing either loss (left) or gain 754	  
(right) of mCpG at the TSS according to the WGBS analyses. Hierarchical clustering 755	  
analyses of the overlapping genes are presented as heatmaps of TPMs scaled per gene 756	  
(Z-score). 757	  
 758	  
Extended Data Figure 5: 5hmC levels increase in ductal cells in vitro and in vivo 759	  
upon damage  760	  
a-c, EpCAM+ ductal cells sorted from 0.1% DDC livers (a), β1 integrin mutant mice 761	  
fed with normal chow (undamaged) or DDC (b) or WT undamaged livers and grown 762	  
as organoids (c). 5hmC fluorescence intensity was normalised to DAPI. Data are 763	  
presented as violin plots of the ratio 5hmC/DAPI. Each dot represents the median 764	  
value (shown in red) of cells counted/mouse. a, 353 cells from n=4 undamaged mice, 765	  
231 cells from n=5 mice after 3 days of DDC, and 392 cells from n=5 mice at DDC 766	  
d5; b, 138 cells from undamaged, 119 cells at day 1, 247 at day 7 and 125 at day 14 767	  
after returning the mice to normal chow (recovery) pooled from 2 livers isolated 768	  
independently from 2 mice were analysed; c, 2500 (0h), 900 (24h) and 2000 (48h) 769	  
cells from n=3 independent experiments were analysed. p-values were calculated 770	  
using pairwise comparisons with Wilcoxon rank sum test. a, d3 vs d0  p= 1x10-13 ; d5 771	  
vs d0  p< 2.2x10-16 . c, 0h vs 24h  p< 2.2x10-16 ; 48h vs 0h  p< 2.2x10-16. Scale bar, 772	  
10µm. d, All 5hmC sites identified by RRHP. e, Number of genes associated to TSS 773	  
showing differential 5hmC levels. The number of CpG sites (n) with unique gain of 774	  
hydroxymethylation is shown. f, Graphs represent distribution of percentage of mCpG 775	  
identified by WGBS in CGI outside TSS (n=32673) using the average of the 2 776	  
independent samples (violin plots, black lines median, left) and number of 5hmC 777	  
counts (median±IQR) in CGI outside TSS (n=	  25579) (right). g, GO and statistical 778	  
analyses of the clusters identified in Fig. 4j (Cluster 2 n=347; Cluster 3 n=1659; 779	  
Cluster 4 n=1424; Cluster 6 n=140) were performed using DAVID 6.8. Heatmap 780	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shows the expression profile of the 84 overlapping genes and is presented as averaged 781	  
Z score of the 2 biological replicates.  782	  
 783	  
Extended Data Figure 6: TET1 regulates actively transcribed genes in liver 784	  
organoids 785	  
a-d, DamID-sequencing was performed in EpCAM+ sorted ductal cells derived from 786	  
already established liver organoids (3 independent experiments). Only TET1-Dam 787	  
peaks identified in all 3 experiments were considered for further analyses. a, Scheme 788	  
of DamID-seq protocol. b, Heatmaps showing TET1 peaks identified by DamID-seq 789	  
(left panels) and H3K4me3 peaks identified by ChIP-seq (right panels). Heatmaps are 790	  
centred in the middle of the peak (0) and show a genomic window of ±10kb. Top 791	  
heatmaps represent common peaks between TET1 and H3K4me3 (2848 peaks) while 792	  
bottom heatmaps represent TET1-specific peaks (2254 peaks). c, Pie-chart indicates 793	  
the percentage of genomic distribution of TET1-Dam peaks. d, GO and statistical 794	  
analyses of biological processes among TET1-Dam targets in liver organoids were 795	  
performed using DAVID 6.8. n, number of genes. e, 5hmC and 5mC levels 796	  
determined by MeDIP and hMeDIP followed by qPCR on the indicated genomic 797	  
region surrounding Lgr5 TSS in WT (black), Tet1hypo/hypo (blue) and hypo-OE (red) 798	  
organoids. Graphs represent mean of n=3 independent experiments. Student's two 799	  
tailed was performed comparing samples to WT. *, p<0.05; ** =p <0.01 f, TET1 800	  
ChIP-qPCR at Lgr5 TSS (left panel) and Lgr5 mRNA levels (right panel) in WT, 801	  
Tet1hypo/hypo and hypo-OE organoids. Graphs represent mean±SD of n=3 independent 802	  
experiments. Student's two tailed t-test statistical analyses were performed vs WT. **, 803	  
p <0.01 g, Sorted EpCAM+ cells from WT livers were cultured in organoid medium 804	  
and harvested for DNA, chromatin and mRNA expression analyses at the indicated 805	  
time points. Graphs represent mean of n=3 independent experiments. Student's two 806	  
tailed t-test analyses were performed vs t=0h *, p<0.05; ** =p <0.01; *** =p <0.001 807	  
 808	  
Extended Data Figure 7: Treatment with Rapamycin impairs organoid 809	  
formation 810	  
a, EpCAM+ ductal cells freshly isolated from the undamaged liver were treated at 0-811	  
18hrs or 18-48hrs with the indicated small molecule inhibitors. Organoid formation 812	  
was quantified at day 6. Graph represents organoid formation efficiency and indicates 813	  
mean ±SD of n=3 independent experiments. Statistical analyses were performed with 814	  
two-ways ANOVA with Bonferroni’s multiple compared test (vs DMSO control 815	  
group). DMSO control quantifications are shown in Fig. 6f. Representative pictures of 816	  
organoids treated with the inhibitors at 18-48hrs are shown.  817	  
 818	  
Extended Data Figure 8: TET1 hypomorphic mice present a significantly 819	  
impaired ductal regeneration upon damage. 820	  
a, Graph represents mean ±SD of mouse weight of WT (n=21 mice), Tet1hypo/+ (n=13 821	  
mice) and Tet1hypo/hypo (n=27 mice) littermates. Student's two tailed t-test statistical 822	  
analyses were performed. b, Relative mouse weight of WT (n=5), Tet1hypo/+ (n=1) and 823	  
Tet1hypo/hypo (n=5) mice. c, Representative H&E stainings (3 experiments)  of 824	  
intestines from 50 week old WT and Tet1hypo/hypo mice. Scale bar, 100µm. d, 825	  
Representative H&E stainings (3 experiments) of small intestine from 10 week old 826	  
WT and Tet1hypo/hypo mice treated with DDC for 5 days. Scale bar, 100µm. e-f, Box-827	  
and-whisker plots showing median and IQR of proliferating ductal cells 828	  
(OPN+/Ki67+) during recovery (n=3 WT and n=4 Tet1hypo/hypo mice) (e) or total ductal 829	  
cells (OPN+) at the different time points indicated (f) (Undamaged, n=3 WT and n=3 830	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Tet1hypo/hypo mice ; DDC, n=7 WT and n=6 Tet1hypo/hypo mice; Recovery, n=3 WT and 831	  
n=4 Tet1hypo/hypo mice). Grey dots, outliers from a single counted FOV defined as >1.5 832	  
IQR above or below the median. Red squares, median level corresponding to each 833	  
independent mice. p-values obtained by two-sided Kolmogorov-Smirnov test. g, 834	  
Population distribution of the total number of ductal cells (OPN+) Dashed lines show 835	  
median values obtained from 55 FOV for WT (3 mice) and 56 FOV for Tet1hypo/hypo 836	  
(3mice) at day 0 (undamaged) and 110 FOV for WT (3 mice) and 153 FOV for 837	  
Tet1hypo/hypo (4 mice) at day 12 (recovery). h, PCK immunohistochemistry (3 838	  
experiments) from WT (left) and Tet1hypo/hypo (right) undamaged or in recovery after 839	  
DDC (day 12) livers. Nucleus, Haematoxylin. Scale bar, 100µm. i, Lgr5 and Tet1 840	  
mRNA levels, TET1 ChIP and hMedIP on Lgr5 TSS were analysed in undamaged 841	  
and DDC treated livers. Graphs represent mean±SD of values obtained from n=3 842	  
independent biological replicates (dot). p-value was calculated using Student's two-843	  
tailed t-test. 844	  
 845	  
Extended Data Figure 9: Ductal specific Tet1 conditional deletion impairs duct-846	  
mediated liver regeneration 847	  
a, Schematic of the Prom1CreERT2/RosalslZsGreen/Tet1flx/flx mouse model. b, 848	  
Representative immunofluorescence analysis (OPN+ red, ZsGreen+, green) of 849	  
Prom1∆Tet1/ZsGreen and Prom1Tet1WT/ZsGreen upon tamoxifen treatment and injection of 850	  
AAV8-TBG p21 (2 mice per genotype). Nucleus, Hoechst. Scale bar, 50 µm c, 851	  
Representative immunofluorescence analysis of livers from Prom1Tet1WT/ ZsGreen mice 852	  
injected with AAV8-TBG p21 not receiving tamoxifen treatment (2 mice per 853	  
genotype). Scale bar, 100 µm. d, Tet1 expression in EpCAM+/ZsGreen+ ductal cells 854	  
isolated by FACS from Prom1∆Tet1/ZsGreen (n=4) or Prom1Tet/ZsGreen (n=4) livers derived 855	  
from mice treated for 3-cycles of DDC and collected 12 days after damage. Graph 856	  
represents mean±SD of Tet1 expression expressed as a fold change compared to 857	  
Prom1Tet1WT. Student's two tailed t-test statistical analyses were performed. ***, 858	  
p<0.001. e, Representative pictures of P21 immunohistochemistry analyses. Scale bar, 859	  
200 µm. f, Weight curves of mice undergoing AAV8-TBG-p21 injection followed by 860	  
DDC treatment (mean± 95%CI). g, TET1 ChIP-qPCR analyses on target genes in 861	  
ZsGreen+/EpCAM+ ductal cells isolated from Prom1Tet1WT/ZsGreen DDC-treated livers 862	  
for 5 days. Cells isolated from 3 mice littermates were pooled used for each 863	  
independent experiment (n=2). ND, not detected. h, Graph represents mean ±SD of 864	  
mRNA expression of Tet1 and selected target genes (fold change vs WT undamaged) 865	  
in EpCAM+ ductal cells isolated from undamaged (n=2 per genotype) or day 5 DDC-866	  
treated livers (n=3 per genotype) derived from Prom1TET1WT/ZsGreen (grey) or 867	  
Prom1∆Tet1/ZsGreen (blue) mice. Statistical analysis was performed using Student's two-868	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 Methods: 1085	  
Liver isolation, FACS sorting, culture and transfection 1086	  
Undamaged or DDC damaged livers were isolated from 8-12 weeks old mice and 1087	  
digested using collagenase/dispase (0.125mg/ml in DMEM/F12) as previously 1088	  
published4,70. To obtain a population of ductal cells, cells were stained with CD11b-1089	  
PE/Cy7 (BD Biosciences), CD45-PE/Cy7 (BD Biosciences), CD31-PE/Cy7 (Abcam) 1090	  
and EpCAM-APC antibody (eBioscience) (Supplementary Dataset 5) and FACS-1091	  
sorted using a MoFlo cell sorter. The following sorting strategy was pursued: single 1092	  
cells were sequentially gated based on cell size (forward scatter, FSC, versus side 1093	  
scatter, SSC) and singlets (pulse width vs FSC) and then ductal cells were selected 1094	  
based on EpCAM positivity after excluding macrophages (CD11+), blood cells 1095	  
(CD45+) and endothelial cells (CD31+), hence obtaining a pure population of single 1096	  
CD11b-/CD31-/CD45-/EpCAM+, named EpCAM+ from here on (see Supplementary 1097	  
Dataset 5 for antibody list). In order to determine the phase of the cell-cycle, 1098	  
EpCAM+ cells derived from R26Fucci2a mice35 were further gated for mCherry-1099	  
hCtd1(30/120) (G1/G0) and mVenus-hGem(1/110) (S/G2/M).  1100	  
Sorted cells were seeded in matrigel and cultured in Advanced DMEM/F12 (Gibco) 1101	  
supplemented with Penicillin/Streptomycin, Glutamax and HEPES (all from Gibco), 1102	  
and 1xN2 (Gibco), 1xB27 (Gibco), 500nM n-Acetylcysteine (Sigma), 10nM Gastrin 1103	  
(Sigma), 50ng/ml EGF (Peprotech), 100ng/ml FGF10 (Peprotech), 50ng/ml HGF 1104	  
(Peprotech), 10mM Nicotinamide (Sigma), 10% R-spondin1 conditioned medium 1105	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(home-made), 25ng/ml Noggin (Peprotech), 30% Wnt conditioned medium (home-1106	  
made) and 10uM of Rock inhibitor Y-27632 (Sigma), as previously reported4,70. After 1107	  
48h, Wnt conditioned medium, Noggin and Rock inhibitor were removed from the 1108	  
culture medium. 1109	  
Organoid formation efficiency from ductal sorted cells was determined by seeding 1110	  
single cells at 500 cells/well and counting organoid numbers/well 6 days later. 1111	  
Organoid formation efficiency from organoid cultures was determined by dissociating 1112	  
organoids into single cells following TrypleE (Gibco) incubation for 10min. Cells 1113	  
were then seeded at 500 cells/well and number of organoids/well was counted after 6 1114	  
days. 1115	  
For experiments with small molecule inhibitors, EpCAM+ ductal cells were grown for 1116	  
the time and concentration indicated in the legend with Verteporfin (Tocris, 5305), 1117	  
Gefinitib (Stratech Scientific, S1025), PD0325901 (Sigma, PZ0162), Rapamycin 1118	  
(Sigma, R8781) and PD173074 (Tocris, 3044).  1119	  
For EdU studies, a 24h pulse of EdU was performed in FACS-sorted EpCAM+ cells at 1120	  
0-24h, 24-48h, 48-72h after seeding. Cells were then cytospun, using to Click-iT EdU 1121	  
Alexa Fluor 594 Imaging Kit (Molecular Probes) according to manufacturer’s 1122	  
instructions.  1123	  
For treatment of CreERT2 positive cells in vitro, 5mM of (Z)-4-Hydroxytamoxifen 1124	  
(Sigma) was added o/n to the medium.  1125	  
To perform siRNA experiments, 1x104 EpCAM+ cells freshly isolated from 1126	  
undamaged livers were transfected either with a pool of 4 ON-Targetplus siRNA 1127	  
(Dharmacon) for each candidate gene (screen) or with 4 independent Tet1 siRNA, 1128	  
using Lipofectamine RNAimax (Life Technologies) according to manufacturer’s 1129	  
instructions. Briefly, cells and Lipofectamine-RNA mix were spun at 600g at 32°C or 1130	  
45min and then incubated 4h at 37C. Cell suspension was then collected and seeded 1131	  
in matrigel in Isolation medium. Organoid formation efficiency was assessed 6 days 1132	  
later. siRNAs used are listed in Supplementary Dataset 5.  1133	  
To generate stable organoid lines, ectopically expressing full-length hTET1 cDNA 1134	  
(TET1wt) or catalytically inactive TET1 (H1671Y, D1673A) (TET1 cat.mut.) 1135	  
reported in29,39. Cells were transfected into 5x104 CD11b-/CD31-/CD45-/EpCAM+ 1136	  
freshly isolated cells using Lipofectime 2000 (Life Technologies) according to 1137	  
manufacturer’s instructions. Briefly, cells and Lipofectamine-DNA mix were spun at 1138	  
600g at 32°C for 45min and then incubated 4h at 37C. Cell suspension was then 1139	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collected, spun for 5min at 300g and seeded in matrigel in Isolation medium for 48h 1140	  
and then switched to expansion medium. Blasticidin (2µg/ml) was added 48h after 1141	  
transfection in expansion medium in order to maintain stable expression of the 1142	  
transgenes. Organoid formation efficiency was assessed 6 days later. 1143	  
hTET1 cDNA was cloned into a Mammalian Targeted DamID vector with a CAG-1144	  
promoter downstream of LT3-Dam43	   to create a Dam-hTET1 fusion protein using 1145	  
Gibson assembly. Organoids were transiently transfected as described above with 1146	  
either a Dam-only or Dam-hTET1 fusion construct, together with pCAG-Venus at a 1147	  
3:1 ratio. Around 5×103, 2.5×104 and 4.5×104 Venus+ cells were FACS-sorted 72h 1148	  
later and processed independently for each the 3 biological replicates respectively.  1149	  
 1150	  
5hmC/EdU immunocytochemistry 1151	  
EdU/5hmC staining was performed in FACS-sorted cells fixed in 4% 1152	  
paraformaldehyde (PFA) at time (0h) or embedded in matrigel and cultured in 1153	  
Isolation Medium for 24h and 48h. For the latter two conditions, EdU was added to 1154	  
the medium at 10µM for a 24h pulse (namely from 0-24h and from 24-48h). Cells 1155	  
were fixed with 4% PFA within the matrigel bubble and extracted by washing with 1156	  
cold Advanced DMEM/F12. Cells were cytospun onto SuperFrost Plus slides (VWR) 1157	  
and stained using the Click-iT EdU Alexa Fluor 594 Imaging Kit (Molecular Probes) 1158	  
according to manufacturer’s instructions. Cells were permeabilised and blocked 1159	  
simultaneously with PBS containing 1% Triton, 1% DMSO, 1% BSA and 2% donkey 1160	  
serum for 25min, after which they were treated with 2N HCl at RT for 20min. 1161	  
Following thorough washes with PBS, the cells were incubated with the 5hmC 1162	  
primary antibody (Active Motif, 39769, Supplementary Dataset 5) at 1:1000 dilution 1163	  
in permeabilisation/blocking buffer pre-diluted 1:100 in PBS. After washing with 1164	  
PBS, cells were incubated for 90min with an anti-rabbit Alexa 488 secondary 1165	  
antibody at a 1:250 dilution in PBS containing 0.05% BSA. Nuclei were 1166	  
counterstained with DAPI at 0.5µg/ml in water. Cover slips were mounted with 1167	  
Vectashield (Vector Laboratories) and sealed with nailpolish. The quantification of 1168	  
the intensity of 5hmC levels was performed with an in-house designed macro for the 1169	  
Fiji software 71; EdU+ cells were counted manually.  1170	  
Confocal images were captured on a Leica SP5 inverted confocal microscope, (LAS 1171	  
AF) and processed with Volocity 6.3 (PerkinElmer). The quantification of the 1172	  
	   33	  
intensity of 5mC levels was performed with an in-house designed macro for the Fiji 1173	  
software. 1174	  
 1175	  
Whole Genome Bisulfite Sequencing (WGBS) library preparation and analysis  1176	  
Ductal cells were isolated from 2 independent 8-12 weeks old mice per time point and 1177	  
split for libraries preparation. High-molecular-weight genomic DNA (HMW gDNA) 1178	  
was extracted by first lysing the cells in lysis buffer [20mM Tris pH8, 4mM EDTA, 1179	  
20mM NaCl, 1%SDS] and proteinase K [ThermoFisher, #EO0491] for 90min at 1180	  
56ºC), then by treating lysate with RNase A (#EN0531, ThermoFisher) for 5min at 1181	  
RT. gDNA was extracted using Phenol/chloroform (Phenol:Chloroform:Isoamyl 1182	  
Alcohol 25:24:1, Invitrogen #15593031). HMW gDNA was then sonicated to 1183	  
fragment size of 300-400bp (Covaris, E220), following manufacturer’s instructions. 1184	  
Fragments were then purified using PureLink PCR Purification kit (ThermoFisher, 1185	  
#K310001) and purity and length were determined using NanoDrop, Qubit and 1186	  
Tapestation (Agilent). To estimate bisulfite conversion efficiency, un-methylated 1187	  
lambda phage cl857 Sam7 DNA was used as spike-in (0.5% of total DNA amount). 1188	  
Typically, NGS libraries were prepped using 200ng of sonicated fragments using 1189	  
NEBNext Ultra II DNA Library Prep, following manufacturer’s instructions (New 1190	  
England BioLabs, E7645S). Briefly, blunt fragments are first end-repaired and A-1191	  
tailed using T4 DNA polymerase and Klenow Fragment. They are then ligated on 1192	  
both flanks with Illumina methylated adaptors (NEB, E7535S). Adapted fragments 1193	  
were then purified with Agencourt AMPure Beads at a 0.8x ratio (Beckman Coulter, 1194	  
Inc). Libraries (~50ng) were then treated with sodium bisulfite according to the 1195	  
protocol (Imprint DNA Modification Kit; Sigma, MOD50) and then barcoded 1196	  
(NEBNext Multiplex Oligos for Illumina, NEB E7335S) and amplified by PCR (8 1197	  
PCR cycles) with KAPA HiFi HS Uracil+ RM (KAPA Biosystems). Indexed libraries 1198	  
were sequenced on HiSeq 4000 (High Output mode, v.4 SBS chemistry, at CRUK, 1199	  
Cambridge Institute, UK) to generate 150bp paired reads.  1200	  
Quality of sequenced read pairs was determined, and adaptor sequences and low 1201	  
quality reads removed using TrimGalore --paired --fastqc –illumina 1202	  
(v0.4.4_dev, Babraham Inst.). Adaptor-trimmed paired reads were aligned to the 1203	  
mouse assembly GRCm38.p6 and to the lambda genome (used to determine bisulfite 1204	  
non-conversion rate) using Bismark27 (v0.19.0). Single-end reads from un-aligned 1205	  
paired-end reads were also mapped. Alignment parameters were: 1 mapping mismatch 1206	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allowed with a maximum insert size for valid paired-end read alignments of 500bp (-1207	  
N 1 –X 500, respectively). Clonal reads were removed using deduplicate_bismark. 1208	  
Methylation at CpG sites was called using bismark_methylation_extractor —1209	  
no_overlap --ignore_r2 2 and methylpy call-methylation-state using 1210	  
merged paired end and single end reads. Biological duplicates were merged for overall 1211	  
methylome profiling and only CpG sites with ≥3 unique mapped reads were used for 1212	  
analyses. DMRs (default parameters with DNA methylation differences of ≥25% 1213	  
between groups) were generated using R package DSS (v2.26.0) and CGI for 1214	  
GRCm38.p6 were predicted as previously published72. For analysis of cytosine 1215	  
modifications (5mC and 5hmC) on up-regulated genes in vivo, levels of modification 1216	  
at CpG context (mCpG) were averaged over TSS regions (+/- 500bp) of genes (given 1217	  
as percentage of mCpG). WGBS analyses, including gene expression correlation and 1218	  
Spearman correlation, were done using DSS (v2.26.0), methylpy (v1.2.9), R (v3.4.4), 1219	  
using custom scripts. Samtools (v1.5) and bedtools (v2.26.0) were used to generate 1220	  
and analyse mapped reads. R packages ggplot2 (v2.3.0) and pheatmap (v1.0.10) were 1221	  
used to visualise data. 1222	  
 1223	  
Reduced Representation of Hydroxymethylation Profile (RRHP) library 1224	  
preparation and analysis 1225	  
Genomic DNA from was extracted using phenol/chloroform as described in WGBS 1226	  
section. Quality and purity of gDNA was assessed using Nanodrop and Tapestation. 1227	  
500ng of gDNA was then used to produce RRHP data according to manufacter’s 1228	  
instructions (Zymo Research D5450). RRHP libraries were multiplexed and 1229	  
sequenced on HiSeq 4000 at Gurdon Institute (single end 50bp). 1230	  
Adaptor sequences in sequenced reads and low-quality reads were removed using 1231	  
trimGalore (0.4.4_dev, options: --rrbs --fastqc --illumina). Trimmed reads 1232	  
were then mapped to GRCm38.p6 mouse genome using bowtie2 (version 2.3.3.1, 1233	  
options: --end-to-end). Then, only reads with the 5ʹ-CCGG tag were further 1234	  
analysed. Unique CCGG sites were counted genome-wide and only 5hmC sites 1235	  
present in both biological replicates were analysed. To identify differential 1236	  
hydroxymethylation levels, TSS regions (+2,-1 kbp around TSS) showing ≥4 unique 1237	  
5hmC sites at any time points were analysed. Heatmaps of 5hmC show scaled values 1238	  
of absolute 5hmC count at TSS present in both biological replicates for each group. 1239	  
The non-parametric Kruskal-Wallis test by ranks was used to compare 5hmC levels 1240	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between groups, followed by Dunn’s test to correct for multiple testing (adjusted p-1241	  
values of <0.05 were considered significant). Statistical tests were performed using 1242	  
Prism (v8.0). 1243	  
 1244	  
Time-lapse microscopy and Image analysis 1245	  
Time-lapse images of single FACS-sorted ductal cells were acquired on an inverted 1246	  
spinning disk confocal microscope (3i Intelligent Imaging Innovations) with a Zeiss 1247	  
LD C-Apochromat 40x (1.1 numerical aperture, NA) immersion objective. Cells were 1248	  
imaged in a humidified chamber with 5% CO2. Images were taken at intervals of 1249	  
60min with a Z-step of 2.4µm. Time-lapse acquisition were processed with the 1250	  
Slidebook6 software and analysed by Fiji image processing software, as previously 1251	  
described73. 1252	  
 1253	  
RNA-sequencing and analyses 1254	  
EpCAM+ freshly isolated cells were isolated from undamaged or DDC-damaged 1255	  
livers (day 3 and 5) for RNA extraction or embedded in matrigel and collected at 1256	  
different time points after culture (time 12h, 24h, 48h and 6 days, the later named as 1257	  
organoids). The starting time point (0h) was collected after seeding in matrigel but 1258	  
prior to adding any medium. Total RNA was extracted using PicoPure RNA isolation 1259	  
kit (ThermoFisher Scientific) according to manufacturer’s instructions. RNA libraries 1260	  
were prepared by using Smartseq274. RNA sequencing was performed using Illumina 1261	  
Hiseq sequencer at the Gurdon Institute. Quality of sequenced read pairs was 1262	  
determined, adaptor sequences and low quality reads removed using TrimGalore --1263	  
paired --fastqc --illumina (v0.4.4). Reads were mapped and quantified (TPM) 1264	  
using kallisto v0.43.1 (kallisto quant --bias --single -b 100 -l 500 -s 80 1265	  
-t 1) with the mouse assembly GRCm38.p6. Differential gene expression was 1266	  
performed using sleuth (v0.29.0; sleuth_lrt: likelihood ratio test) with FDR <0.1, with 1267	  
sequencing batch effect adjustment. Only DE genes with a maximal TPM of >5 at >1 1268	  
time point (T0, D3 or D5) and showing considerable expression level difference 1269	  
(|b|>0.58) were analysed. Principal component analysis (centered and scaled) were 1270	  
produced with build-in R programme prcomp. Mean TPM values between biological 1271	  
replicates of each group were used for downstream analysis. Graphs and heatmaps 1272	  
were produced with R packages ggplot2, rgl and pheatmap. Heatmap of gene 1273	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expression are scaled TPM values (z score). The list of epigenetic regulators was 1274	  
found in the database Epifactors37.  1275	  
 1276	  
Organoid whole mount immunostaining 1277	  
Organoids removal from matrigel was performed by mechanically disrupting the 1278	  
matrigel by gently pipetting 5 times and then incubated for 10min in cold Advanced 1279	  
DMEM/F12 medium. Cells were fixed with PFA 4% for 30min on ice and incubated 1280	  
with blocking solution (PBS 1%Triton 1%BSA in PBS) for 1.5 hours. For 5hmC 1281	  
staining, organoids were treated for 20min with 2N HCl before incubation with the 1282	  
primary antibody followed by 3 washes in 1% blocking solution. Primary antibodies 1283	  
were incubated o/n at 4°C Fluorophore-conjugated secondary antibodies were then 1284	  
incubated for 2h. Nuclei were stained with DAPI. Confocal images were captured on 1285	  
a Leica SP5 inverted confocal microscope and processed with Leica LasX software.  1286	  
 1287	  
Quantitative PCR (qPCR) 1288	  
Total RNA was extracted from freshly isolated EpCAM+ cells or cultured in isolation 1289	  
or expansion medium (organoid cultures) using PicoPure RNA isolation kit 1290	  
(ThermoFisher Scientific) according to manufacturer instructions. cDNA was 1291	  
synthesized using 50-250ng of total RNA and a M-MLV Reverse Transcriptase kit 1292	  
(Promega). cDNA was amplified with iTaq™ Universal SYBR Green Supermix 1293	  
(BioRad) and specific primers (see Supplementary Dataset 5). All targets were 1294	  
amplified (40 cycles) on a CFX96 Real-Time qPCR Detection System (Biorad). Ct 1295	  
values were analyzed using BioRad CFX manager. Expression levels were 1296	  
normalized to the expression of the housekeeping gene Hprt.  1297	  
 1298	  
5mC and 5hmC DNA immunoprecipitation (MeDIP and hMeDIP) and 1299	  
chromatin immunoprecipitation (ChIP) 1300	  
Genomic DNA was extracted by incubating either sorted EpCAM+ cells (freshly 1301	  
isolated or cultured in matrigel in isolation or expansion medium) or dissociated 1302	  
organoids with lysis buffer (50mM Tris HCl PH8.0, 50mM NaCl, 5mM EDTA, 1.0% 1303	  
SDS) for 10min at 4°C Genomic DNA was sheared by sonication (Bioruptor, 1304	  
Diagenode) to 200-500bp average fragments and purified using MinElute PCR 1305	  
purification micro kit (Qiagen). The following immunoprecipitation buffer was used: 1306	  
50mM Tris HCl PH8, 250mM NaCl, 5mM EDTA, 0,5% Triton, 0,10% SDS. TET1 1307	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(Millipore 09-872 and ABE1034) and H3K4me3 (Diagenode C1541003) primary 1308	  
antibodies (Supplementary Dataset 5) were incubated o/n and immunocomplexes 1309	  
were recovered with DiaMag Protein A or G coated magnetic beads (Diagenode). 1310	  
ChIP-qPCR experiments were then performed on genomic regions of interest and data 1311	  
were normalised to IgG and expressed as percentage of input material (see 1312	  
Supplementary Dataset 5 for primer list). Chromatin Immunoprecipitation (ChIP) 1313	  
experiments from cells freshly isolated from liver tissue were performed using 1314	  
LowCell ChIP kit (Diagenode) followed by iPure kit v2 (Diagenode) according to 1315	  
manufacture’s instructions. ChIP experiments for cells grown in vitro as organoid 1316	  
were performed as previously described75. DNA derived from 2 independent 1317	  
biological H3K4me3 ChIP experiments in liver organoids was pulled and processed 1318	  
using Thruplex DNA seq kit according to manufacturer’s instructions. The library 1319	  
was sequenced in-house using an Illumina Hiseq 1500. H3K4me3 ChIP-seq reads were 1320	  
mapped to GRCM38/mm10 with bowtie2 (v2.2.9). Peak calling on H3K4me3 ChIP-1321	  
seq was done using MACS2 (v2.1.0) (broad, q<0.01) on individual bam-files, with 1322	  
input as a control. Genes were called from peaks using GREAT (v3.0.0)76 (single 1323	  
nearest gene, +/-2kb from TSS). Plots were generated through SeqPlots (v1.12.1)77.	  1324	  
 1325	  
DamID sequencing  1326	  
Cells obtained by trypsin-mediated dissociation of mouse liver organoids were 1327	  
transfected with hTET1-Dam or Dam-only vector together with Venus-enconding 1328	  
plasmid (see above). DamID-seq on Venus+ FACS-sorted cells was performed as 1329	  
previously described42. All sequencing experiments were performed as single-end 1330	  
50bp reads generated by the Gurdon Institute NGS Core using an Illumina HiSeq 1331	  
1500. DamID sequencing data from three paired replicates were mapped to 1332	  
GRCM38/mm10 and processed using the damidseq_pipeline script78, with default 1333	  
settings apart from a 300 bin-width. Peak-calling on DamID samples was done using 1334	  
MACS2 (v2.1.0) (broad, q<0.01) on individual bam-files, with Dam-only as control. 1335	  
Peak files from all replicates were merged and intersected with every single replicate 1336	  
with bedtools (v2.25.0) to obtain those peak-regions, which were only present in all 1337	  
three replicates with a q-value <0.01. Genes were called from peaks using GREAT 1338	  
(v3.0.0)76 (single nearest gene, +/-2kb from TSS). Plots were generated through 1339	  
SeqPlots (v1.12.1)77.	  Peaks were annotated to overlapping genomic features with the 1340	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ChIPseeker-package (v1.18.0) in R using annotations and gene IDs from 1341	  
TxDb.Mmusculus.UCSC.mm10.knownGene and org.Mm.eg.db (v3.4.4). DamID data 1342	  
are presented as Dam-hTETt1/Dam ratios with the midline at 1. 1343	  
 1344	  
Western blot assay 1345	  
Cell lysates were prepared using RIPA buffer (10mM Tris-Hcl PH 8.0m 1mM EDTA, 1346	  
1% Triton X-100, 0.1% SDS. 150mM NaCl) supplemented with proteinase inhibitor 1347	  
cocktail (Roche) and sonicated for 5min using a Bioruptor sonicator (Diagenode). 1348	  
Lysates were cleared by centrifugation at 13,000rpm for 15min. Samples were loaded 1349	  
on Precast Mini Protean TGX gels (Biorad) and transferred on nitrocellulose 1350	  
membrane (Biorad), which was blocked in 5% milk and incubated O.N. with TET1 1351	  
(Millipore 09-872) (1:1000) or actin (Abcam ab3280) (1:2000) (Supplementary 1352	  
Dataset 5). Then, anti-rabbit or mouse horseradish peroxidase (HRP) conjugated 1353	  
secondary antibodies were used and antibody-protein complexes were visualised 1354	  
using ECL (GE-Healthcare). Bands intensities were quantified using Fiji software. All 1355	  
antibodies used are listed in Supplementary Dataset 5. 1356	  
 1357	  
Mouse line generation and maintenance  1358	  
All mouse experiments have been regulated under the Animals (Scientific 1359	  
Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the 1360	  
University of Cambridge Animal Welfare and Ethical Review Body (AWERB). All 1361	  
animal experiments have been performed in adult (>8 weeks-old) mice. Both female 1362	  
and male mice were used. The R26Fucci2a mouse line was generated from a cross 1363	  
between the previously described R26Fucci2aR35 and Cre745 mouse lines (a kind gift 1364	  
from DJ Kleinjan, University of Edinburgh). Cre745 mice ubiquitously express Cre-1365	  
recombinase under the control of the CAAG promoter79, the resulting progeny of this 1366	  
cross therefore had permanently excised the STOP cassette in the R26Fucci2aR locus 1367	  
resulting in ubiquitous expression of Fucci2a. The CAAG-Cre transgene was crossed 1368	  
away in subsequent matings. The “knock-out first” Tet1tm1(KOMP)Wtsi mouse line 1369	  
(named as Tet1hypo/hypo line)  was obtained from the International Knockout Mouse 1370	  
consortium (IKMC).  To ensure mouse fertility the line was initially crossed with 1371	  
MF1 mice to generate a C57/Bl6xMF1 mixed background. All further generated mice 1372	  
were inbred within this line to maintain this mixed background. In order to generate 1373	  
the Tet1 conditional (Tet1flx/flx) mouse line, Tet1tm1(KOMP)Wtsi mice were bred with a 1374	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ubiquitously expressing Flipase recombinase (Rosa26FLPe), taking advantage of 1375	  
built-in frt sites, leaving only loxP sites flanking exon 4 of Tet1 (NM_001253857). 1376	  
For TET1 conditional deletion, Tet1flx/flx mice were bred with either the ubiquitous 1377	  
Rosa26CreERT2 (JAX lab, ROSA26Sortm1(cre/ERT2)Tyj/J) or the ductal specific 1378	  
Prom1CreERT2  Cre drivers57. Deletion of exon 4 was induced in 8-10 weeks old mice 1379	  
by 3 intraperitoneal injections of tamoxifen, performed at 48h intervals, at a dose of 1380	  
either 4mg or 0.2 mg/g (see specific experimental scheme for dosage) diluted in 1381	  
sunflower oil. 1382	  
 1383	  
DDC treatment  1384	  
For Acute DDC treatment, adult mice were transferred to wheat-free cages and fed 1385	  
with food supplemented with 0.1% DDC (Custom Animal diets, LLC). The diet was 1386	  
provided ad libitum for the duration of the experiment (2-5 days) or switched back to 1387	  
normal chow after 5 days. Mice were allowed to recover for 7 days.  1388	  
Chronic DDC experiments were performed by supplementing the diet with 0.1% 1389	  
DDC for 5-days for eight cycles, with a 3-day interval of normal diet between cycles. 1390	  
All mice were euthanized by exposure to CO2, and, when required, blood was 1391	  
collected by cardiac puncture. Serum was then submitted for analysis at the 1392	  
Department of Veterinary Medicine, University of Cambridge.  1393	  
 1394	  
P21 overexpression and DDC treatment 1395	  
Lineage tracing and Tet1 deletion in Prom1CreERT2/RosaIslZsGreen/Tet1flx-flx mice was 1396	  
induced as described above. After one week, 7.5x1011 viral particles of AAV8-TBG-1397	  
p21 were injected intravenously (by tail vein injection) as previously described9. After 1398	  
a week of wash out (allowing for a combined two-week wash out from tamoxifen 1399	  
injections), the mice were fed chow supplemented 0.1% DDC ad libitum for 5 days in 1400	  
three cycles each with 3 days of recovery in between DDC treatments. After 2 weeks 1401	  
recovery time after the final DDC dose, mice were culled and analysed.  1402	  
 1403	  
Histology and immunohistochemistry 1404	  
Livers and small intestines were removed and fixed in 10% neutral buffered formalin 1405	  
(Sigma-Aldrich) overnight at room temperature. After fixation tissues were frozen in 1406	  
O.C.T compound (VWR chemicals) or embedded in paraffin (Thermo Scientific) and 1407	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processed for analysis. For Haematoxylin and Eosin (H&E) and pan-cytokeratin 1408	  
staining, 5µm paraffin embedded sections were deparaffinised by washing in Xylene 1409	  
followed by descending concentrations of ethanol (100%, 95%, 70% 50%). Slides 1410	  
were then either stained for standard H&E analysis or immunostained with a pan-1411	  
cytokeratin (PCK) antibody (Supplementary Dataset 5). For the PCK 1412	  
immunostaining, following de-paraffination and hydration, endogenous peroxidase 1413	  
activity was blocked by incubating sections in 3% H2O2:MeOH for 15min at room 1414	  
temperature. Antigen retrieval was performed by incubating the sections in 800 1415	  
units/ul Proteinase K diluted in Tris-EDTA (pH 8) and 0.5% triton X-100 for 10min 1416	  
at 37°C. Sections were allowed to cool to room temperate before being blocked in 1417	  
blocking buffer [2% Normal goat serum, 1% Bovine serum albumin, 0.1% triton X-1418	  
100 in TBS] for 1h at room temperature. Primary antibody was diluted in 1:100 1419	  
dilution of the blocking buffer and incubated o/n at 4C. Antibody detection was 1420	  
carried out using the Bright-DAB system (ImmunoLogic) following manufacturers’ 1421	  
protocol. Sections were counterstained in haematoxylin and mounted in DPX 1422	  
mounting medium.  1423	  
When stated, 5um paraffin sections were stained with Picro-sirius Red according to 1424	  
manufacturer instructions (Abcam, ab150681). Fibrotic area was calculated using a 1425	  
Fiji Image macro developed in house.  1426	  
 1427	  
Immunofluorescence 1428	  
Liver sections (50-100µm thick) were cut from O.C.T. embedded samples and washed 1429	  
in PBS twice. Sections were blocked in 1% Triton X-100 (Sigma-Aldrich), 5% 1430	  
DMSO (Sigma-Aldrich), 2% Donkey Serum (Sigma-Aldrich) for 16h at 4C and 1431	  
incubated with the primary antibody (see Supplementary Dataset 5) diluted in 0.5% 1432	  
Triton X-100, 1% DMSO, 2% Donkey Serum for 72h at 4C. Sections were washed 1433	  
thoroughly over 24h with 0.5% Triton X-100 and 1% DMSO. Appropriate 1434	  
fluorophore conjugated secondary antibodies were diluted in 0.5% Triton X-100, 1% 1435	  
DMSO and 2% Donkey Serum and incubated on sections for 48h at 4C. The sections 1436	  
were washed in PBS and incubated with Hoechst 33342 diluted 1:1000 in PBS for 1h 1437	  
at room temperature. Finally, sections were incubated in ascending glycerol 1438	  
concentrations (10%, 30%, 50%, 70% 90%) for 1h each and then mounted in 1439	  
Vectashield (Vector Laboratories). Stained sections were imaged using a Leica SP5 1440	  
confocal microscopy and analysed in Fiji.  1441	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 1442	  
Code availability: 1443	  
All codes used are available upon request. 1444	  
 1445	  
Statistics and Reproducibility 1446	  
Statistical analyses are described in detail for each panel. Briefly, statistical analyses 1447	  
of ChIP-qPCR, RT-qPCR, cell-culture experiments were performed using Prism 6 1448	  
software. Student two tailed t-test or two ways ANOVA combined with Tukey HSD 1449	  
test were used according to the experiment. Statistical analyses used for identification 1450	  
of DMRs based on WGBS we re identified using DSS.  RRHP and immunostainings 1451	  
were performed using R (v3.4.4). Kruskal Wallis test with Dunns multiple 1452	  
comparisons was used a statistical test for RRHP. Statistical analyses of 1453	  
immunofluorescence data were performed using Wilcoxon rank sum test. Population 1454	  
distributions of the proliferative ductal populations (Ki67+/OPN+ cells) as well as the 1455	  
total ductal populations (OPN+) were compared between genotypes using two sided 1456	  
Kolmogorov-Smirnov test. Distributions were then visualised using box and whisker 1457	  
plots and histograms with kernel density estimate values overlaid. Histogram bin sizes 1458	  
were determined by splitting the total data range into 30 bins of equal size. Frequency 1459	  
density was then calculated by taking the number of counts within each bin and 1460	  
dividing it by bin size and total number of counts in the group.  1461	  
For peak calling of DamID-sequencing and ChIP-sequencing experiments statistics 1462	  
were performed using MACS2. DE genes in the RNA-sequencing were called using 1463	  
Sleuth with Wald test. Statistical analyses of expression of TET1 targets were 1464	  
performed with one-way ANOVA followed by Tukey’s multiple comparisons test. 1465	  
GO analyses were perfomed using DAVID 6.8. n size of the samples was indicated 1466	  
for each panel. No data points were removed. All experiments presented were 1467	  
reproducible.  1468	  
 1469	  
Data availability: 1470	  
RNA, ChIP, DamID, WGBS and RRHP sequencing data that support the findings of 1471	  
this study have been deposited in the Gene Expression Omnibus (GEO) under 1472	  
accession code GSE123133.  1473	  
All other data supporting the findings of this study are available from the 1474	  
corresponding author on reasonable request. 1475	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Supplementary datasets: 1476	  
 1477	  
Movie1: Time lapse movie of EpCAM+ ductal cells FACS-sorted from undamaged 1478	  
R26Fucci2a mouse embedded in matrigel and grown in organoid culture conditions 1479	  
for 72h 1480	  
 1481	  
Supplementary Dataset 1: RNA-sequencing data 1482	  
 1483	  
Supplementary Dataset 2: WGBS and RRHP data  1484	  
 1485	  
Supplementary Dataset 3: TET1-DamID sequencing and H3K4me3 ChIP-sequencing 1486	  
data 1487	  
 1488	  
Supplementary Dataset 4: List of DE genes in vivo and merge with TET1 targets, 1489	  
WGBS and RRHP 1490	  
 1491	  
Supplementary Dataset 5: List of antibodies, primers and siRNA sequenc 1492	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Figure 7_Aloia et al.
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Figure 8_Aloia et al.
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Aloia_Extended Data Figure 06
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Aloia_Extended Data Figure 09
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